Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s12944-020-01278-8

http://scihub22266oqcxt.onion/10.1186/s12944-020-01278-8
suck pdf from google scholar
32493486!7268969!32493486
unlimited free pdf from europmc32493486    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32493486      Lipids+Health+Dis 2020 ; 19 (1): 122
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Alveolar lipids in pulmonary disease A review #MMPMID32493486
  • Agudelo CW; Samaha G; Garcia-Arcos I
  • Lipids Health Dis 2020[Jun]; 19 (1): 122 PMID32493486show ga
  • Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is composed by multiple cell types with specialized functions and coordinately acting to meet specific physiologic requirements. The alveoli are the niche of the most active lipid metabolic cell in the lung, the type 2 cell (T2C). T2C synthesize surfactant lipids that are an absolute requirement for respiration, including dipalmitoylphosphatidylcholine. After its synthesis and secretion into the alveoli, surfactant is recycled by the T2C or degraded by the alveolar macrophages (AM). Surfactant biosynthesis and recycling is tightly regulated, and dysregulation of this pathway occurs in many pulmonary disease processes. Alveolar lipids can participate in the development of pulmonary disease from their extracellular location in the lumen of the alveoli, and from their intracellular location in T2C or AM. External insults like smoke and pollution can disturb surfactant homeostasis and result in either surfactant insufficiency or accumulation. But disruption of surfactant homeostasis is also observed in many chronic adult diseases, including chronic obstructive pulmonary disease (COPD), and others. Sustained damage to the T2C is one of the postulated causes of idiopathic pulmonary fibrosis (IPF), and surfactant homeostasis is disrupted during fibrotic conditions. Similarly, surfactant homeostasis is impacted during acute respiratory distress syndrome (ARDS) and infections. Bioactive lipids like eicosanoids and sphingolipids also participate in chronic lung disease and in respiratory infections. We review the most recent knowledge on alveolar lipids and their essential metabolic and signaling functions during homeostasis and during some of the most commonly observed pulmonary diseases.
  • |1,2-Dipalmitoylphosphatidylcholine/*metabolism[MESH]
  • |Humans[MESH]
  • |Lipid Metabolism/genetics[MESH]
  • |Lung Diseases/*genetics/metabolism/pathology[MESH]
  • |Lung/metabolism/pathology[MESH]
  • |Macrophages, Alveolar/metabolism/pathology[MESH]
  • |Pulmonary Alveoli/*metabolism/pathology[MESH]
  • |Pulmonary Surfactants/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box